See analyst estimates and all valuation multiples for Small Molecules
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $3.2B | 7.2x | 19.5x | |
| $3.1B | 17.6x | 57.1x | |
| $2.2B | 19.4x | -31.6x | |
| $2.1B | 2.8x | 15.9x | |
| $1.8B | 0.7x | 5.7x | |
| $1.8B | 7.1x | 17.4x | |
| $1.7B | 11.0x | -5.4x | |
| $1.5B | 57.6x | -41.9x | |
| $1.2B | 5.3x | 15.8x | |
| $1.1B | 5.1x | 25.1x | |
| $801M | n/a | n/a | |
| $787M | n/a | n/a | |
| $760M | 3.5x | 119.9x | |
| $635M | 3.2x | 13.6x | |
| $584M | 6.9x | 20.3x | |
| $356M | 4.8x | n/a | |
| $344M | 340.0x | -2.0x | |
| $319M | 1.7x | 8.9x | |
| $209M | n/a | n/a | |
| $182M | n/a | -8.5x | |
| $166M | 6.1x | -6.6x | |
| $127M | 1767.1x | -27.4x | |
| $106M | 1.1x | -10.3x | |
| $71.4M | 1.4x | n/a | |
| $33.3M | n/a | -0.2x | |
| $16.6M | 1.3x | n/a | |
| -$27.6M | -34.0x | 0.3x | |
| -$32.6M | -0.4x | 0.3x | |
| -$37.1M | -8.3x | n/a | |
| -$37.2M | n/a | n/a | |
| -$46.3M | -1.5x | 0.4x | |
| -$130M | n/a | n/a | |
| -$243M | -5.6x | 1.3x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Small Molecules